Researchers discover gene behind devastating vitamin B12-related disorder

Swiss, British and Canadian researchers have identified the gene responsible for a rare but serious genetic disorder and have simultaneously provided more clues as to how vitamin B12 works in the body. Their results will be published April 3 in the New England Journal of Medicine.

Scientists at the University Children’s Hospitals of Basel and Zurich in Switzerland, Brunel University in West London, England and McGill University and the McGill University Health Centre (MUHC) in Montreal, Canada, have discovered the MMADHC gene, the role it plays in the metabolism of vitamin B12, and its relationship to the vitamin B12-related disorder, isolated and combined homocystinuria and methylmalonic aciduria (MMA) of the cblD variety..

Authors of the study include Dr. David Coelho, Dr. Terttu Suormala and Dr. Brian Fowler of the University Children’s Hospital, Basel, Dr. David Rosenblatt and his graduate student Jordan Lerner-Ellis of McGill and the MUHC and colleagues at the University Children’s Hospital, Zurich, the University of Zurich and Brunel University. In 2005, Dr. Rosenblatt and his McGill and MUHC colleagues made a related breakthrough involving another gene, called MMACHC.

Isolated and combined homocystinuria and MMA of the cblD variety is a rare genetic inability to process vitamin B12, which is usually diagnosed in infancy or childhood. Patients may suffer from a range of debilitating health problems, including serious developmental delay, psychosis and anemia. Despite the variety of symptoms presented by the disorder, this research shows all of them are caused by mutations in different parts of the same gene.

Vitamin B12 is an essential water-soluble vitamin found in animal-based foods -- including dairy, eggs, meat, poultry, fish and shellfish -- but not in plants. It is vital for the synthesis of red blood cells and the healthy maintenance of the nervous system, and also helps control homocysteine levels.. Excess homocysteine is associated with increased risk of heart disease, stroke and dementia.

“Most patients with B12 problems have difficulty absorbing the vitamin, or may be vegans who don’t get it in their diet,” said Dr. Rosenblatt, Chair of McGill’s Department Human Genetics, Director of Medical Genetics in Medicine at the MUHC, and Chief of Medical Genetics at the Jewish General Hospital. “However, this select group of patients becomes extremely sick because their bodies cannot transform the vitamin into its active forms.”

The research relied heavily on the expertise developed at McGill and Basel as world referral centres for the diagnosis of B12-related genetic diseases, Dr. Rosenblatt said. The study was funded in part by the Canadian Institutes of Health Research (CIHR).

“This important paper - published in the world's highest impact medical journal - is on-going testimony to the international leadership of Dr. Rosenblatt and his colleagues at McGill in their studies of vitamin B12 and the genetic diseases that disrupt the ability of the body to use vitamin B12,” said Dr. Roderick McInnes, Scientific Director of CIHR's Institute of Genetics. “This research also exemplifies the outstanding genetics research done by Canadian scientists.”

“This discovery offers earlier diagnosis and treatment options for this serious disease, and also helps explain the mechanism of how vitamin B12 works in everyone,” said Dr. Rosenblatt.

Source: McGill University

Related stories:

Study finds B-vitamin deficiency may cause vascular cognitive impairment
A deficiency of B-vitamins may cause vascular cognitive impairment, according to a new study. Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University used an experimental model to examine the metabolic, cognitive, and microvascular effects of dietary B-vitamin deficiency. Their findings appear in the August 26, 2008 issue of Proceedings of the National Academy of Sciences (PNAS).
For coronary artery disease patients, B vitamins may not reduce cardiovascular events
In a large clinical trial involving patients with coronary artery disease, use of B vitamins was not effective for preventing death or cardiovascular events, according to a study published in the August 20 issue of JAMA.
Key site in iron metabolism aids in diagnosing anemia of chronic disease
University of Utah School of Medicine researchers have developed a new tool that facilitates diagnosis of anemia related to chronic illness, as well as diseases of iron overload. The results of a study detailing the new tool are published in the August 2008 issue of the journal Cell Metabolism, a publication of Cell Press.
Low vitamin E levels associated with physical decline in elderly
Researchers at Yale School of Medicine have found that a low concentration of vitamin E in the blood is linked with physical decline in older persons.
Tufts researchers update their food guide pyramid for older adults
Tufts University researchers have updated their Food Guide Pyramid for Older Adults to correspond with the USDA food pyramid, now known as MyPyramid. The Tufts version is specifically designed for older adults and has changed in appearance and content. The Modified MyPyramid for Older Adults continues to emphasize nutrient-dense food choices and the importance of fluid balance, but has added additional guidance about forms of foods that could best meet the unique needs of older adults and about the importance of regular physical activity.
Do everyday foods influence risk of prostate cancer?
The biggest ever study on the effect of folate and vitamin B12 on prostate cancer is set to go ahead at Bristol University after World Cancer Research Fund (WCRF) announced it would fund the project.
Vitamin B-12 function may be diminished by excessive folate
In a study of adults aged 20 and over, researchers at Tufts University showed that homocysteine and methylmalonic acid are at much higher levels in individuals who have a combination of vitamin B12 deficiency and high blood folate levels than in individuals who are also vitamin B12 deficient but have normal folate levels.
A vitamin B12 derivative could potentially be used to treat hypertension and heart disease
Investigators at the University of California, San Diego School of Medicine have developed a new drug called nitrosyl-cobinamide. Cobinamide is a vitamin B12 analog, and, in fact, is the penultimate compound in the biosynthesis of vitamin B12 by bacteria. The UCSD investigators have shown that cobinamide binds relatively tightly to nitric oxide (NO), forming nitrosyl-cobinamide.

News discussion:

Medicine & Health news